Edwards Lifesciences Corporation · NYSE:EW

Lippis Daniel J. sold 619 Edwards Lifesciences Corporation shares (Form 4)

Traded Oct 8, 2026 · Filed Oct 8, 2026

On Oct 8, 2026, Lippis Daniel J. (CVP, TAVR) sold 619 Edwards Lifesciences Corporation shares at US$85.65 for US$53,017 under a trading plan, leaving 40,034 shares. Filed Oct 8, 2026 (Form 4).

Sold
619 shares
Price
US$85.65
Value
US$53,017
Holding after
40,034 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CVP, TAVR

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 8, 2026Common StockOption exercise619US$72.6840,653Direct
Oct 8, 2026Common StockSale619US$85.6540,034Direct

Source

View original at SEC

Related